Review article · 2024 · Open access

Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders

Yanqing Zhao, Huijun Yang, Peng Wu, Shuguo Yang, Wenkun Xue, Biao Xu, Sirui Zhang, Bin Tang, Daoxiu Xu

Virulence, 15(1), 2375555 · Published 27 August 2024 · DOI 10.1080/21505594.2024.2375555

Open PDFView at the publisherCite this paper

In brief

“Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders” is a 2024 review article by Yanqing Zhao and 8 co-authors, published in Virulence. OpenAlex counts 164 citations as of 20 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Virulence.

Citations
164
Most cited in
2026 (85)
Field-weighted impact
5.55
References
181
Authors
9

Abstract

Metabolic disease is a worldwide epidemic that has become a public health problem. Gut microbiota is considered to be one of the important factors that maintain human health by regulating host metabolism. As an abundant bacterium in the host gut, A. muciniphila regulates metabolic and immune functions, and protects gut health. Multiple studies have indicated that alterations in the abundance of A. muciniphila are associated with various diseases, including intestinal inflammatory diseases, obesity, type 2 diabetes mellitus, and even parasitic diseases. Beneficial effects were observed not only in live A. muciniphila, but also in pasteurized A. muciniphila, A. muciniphila-derived extracellular vesicles, outer membrane, and secreted proteins. Although numerous studies have only proven the simple correlation between multiple diseases and A. muciniphila, an increasing number of studies in animal models and preclinical models have demonstrated that the beneficial impacts shifted from correlations to in-depth mechanisms. In this review, we provide a comprehensive view of the beneficial effects of A. muciniphila on different diseases and summarize the potential mechanisms of action of A. muciniphila in the treatment of diseases. We provide a comprehensive understanding of A. muciniphila for improving host health and discuss the perspectives of A. muciniphila in the future studies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhao, Y., Yang, H., Wu, P., Yang, S., Xue, W., Xu, B., Zhang, S., Tang, B., & Xu, D. (2024). Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders. Virulence, 15(1), 2375555. https://doi.org/10.1080/21505594.2024.2375555

MLA 9

Zhao, Yanqing, et al. “Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders.” Virulence, vol. 15, no. 1, 2024, p. 2375555. https://doi.org/10.1080/21505594.2024.2375555.

Chicago

Zhao, Yanqing, Huijun Yang, Peng Wu, Shuguo Yang, Wenkun Xue, Biao Xu, Sirui Zhang, Bin Tang, and Daoxiu Xu. 2024. “Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders.” Virulence 15 (1): 2375555. https://doi.org/10.1080/21505594.2024.2375555.

Harvard

Zhao, Y. et al. (2024) ‘Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders’, Virulence, 15(1), p. 2375555. doi:10.1080/21505594.2024.2375555.

IEEE

Y. Zhao et al., “Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders,” Virulence, vol. 15, no. 1, p. 2375555, 2024, doi: 10.1080/21505594.2024.2375555.

BibTeX

@article{zhao2024akkermansia,
  title     = {{Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders}},
  author    = {Zhao, Yanqing and Yang, Huijun and Wu, Peng and Yang, Shuguo and Xue, Wenkun and Xu, Biao and Zhang, Sirui and Tang, Bin and Xu, Daoxiu},
  journal   = {Virulence},
  year      = {2024},
  volume    = {15},
  number    = {1},
  pages     = {2375555},
  doi       = {10.1080/21505594.2024.2375555},
  url       = {https://doi.org/10.1080/21505594.2024.2375555}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202444
20257575
20268585

Its field-weighted citation impact is 5.55: it has been cited 5.55 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • Akkermansia muciniphila
  • probiotics
  • gut microbiota
  • inflammation
  • metabolic disorders
  • obesity
  • type 2 diabetes
  • intestinal inflammatory diseases

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhao, Y., Yang, H., Wu, P., Yang, S., Xue, W., Xu, B., Zhang, S., Tang, B., & Xu, D. (2024). Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders. Virulence, 15(1), 2375555. https://doi.org/10.1080/21505594.2024.2375555

How many times has this paper been cited?

164 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Virulence: sign in and open the PDF from this page.

Who wrote this paper?

Yanqing Zhao, Huijun Yang, Peng Wu, Shuguo Yang, Wenkun Xue, Biao Xu, Sirui Zhang, Bin Tang, Daoxiu Xu.

What is the DOI of this paper?

10.1080/21505594.2024.2375555, permanently at https://doi.org/10.1080/21505594.2024.2375555. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.